marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 05.11.2024
Apellis Pharmaceuticals Gewinn / Verlust 2011-2024 | APLS
Gewinn / Verlust Jährlich Apellis Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
8.28 B | 6.45 B | 3.4 B | 3.33 B | 2.58 B | 738 M | 253 M | - | - | - | - | - | - |
Anteile |
119 M | 106 M | 84.4 M | 75.2 M | 62.2 M | 54.4 M | 13.9 M | - | - | - | - | - | - |
Kurshistorie |
69.7 | 60.8 | 40.3 | 44.3 | 41.1 | 14 | 16.6 | - | - | - | - | - | - |
Nettogewinn |
-529 M | -652 M | -746 M | -345 M | -305 M | -128 M | -51 M | -27.1 M | -46.5 M | -10.8 M | -3.96 M | - | - |
Umsatz |
397 M | 75.4 M | 66.6 M | 251 M | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-517 M | -595 M | -536 M | -214 M | -288 M | -128 M | -50.8 M | -27.3 M | -46.6 M | - | - | - | - |
Zinsaufwendungen |
-727 K | -288 K | 1.36 M | -501 K | -175 K | -25 K | -142 K | 22.4 K | - | - | - | - | - |
EBITDA |
-515 M | -593 M | -535 M | -213 M | -288 M | -125 M | -50.8 M | -27.3 M | 6.4 M | -11.3 M | -4.02 M | - | - |
Betriebsaufwand |
914 M | 670 M | 603 M | 464 M | 288 M | 128 M | 50.8 M | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
501 M | 277 M | 177 M | 139 M | 67 M | 22.6 M | 10.5 M | 4.3 M | 6.36 M | 2.91 M | 1.71 M | - | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich Apellis Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
124 M | 124 M | 123 K | 120 M | 120 M | 119 M | 114 K | 111 M | 109 K | 107 K | 98.1 K | 97.5 M | 85.7 K | 80.7 K | 79.2 M | 76.1 M | 75.6 M | 75.6 M | 73.7 M | 63.9 M | 63.8 K | 63.3 K | 57.9 K | 56.3 M | 56.2 M | 54.7 M | 50.4 M | 50.3 M | 8.44 M | 8.43 M | 8.43 M | 8.43 M | 8.43 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Nettogewinn |
-57.4 M | -37.7 M | -66.4 M | - | -140 M | -122 M | -178 M | - | -191 M | -156 M | -139 M | - | -196 M | -219 M | -184 M | 78.3 M | -136 M | -119 M | -169 M | -113 M | -69.8 M | -71.1 M | -50.6 M | -36.5 M | -36 M | -33.3 M | -21.7 M | -18.3 M | -11.6 M | -12.1 M | -9.05 M | -6.62 M | -7.21 M | -7.29 M | -6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Einnahmen |
197 M | 200 M | 172 M | - | 110 M | 95 M | 44.8 M | - | 22.1 M | 16.3 M | 14.4 M | - | 5.65 M | 623 K | - | - | 646 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-47.3 M | -29.4 M | -62.1 M | - | -137 M | -120 M | -175 M | - | -153 M | -149 M | -129 M | - | -128 M | -194 M | -125 M | 130 M | -130 M | -116 M | -98.8 M | -106 M | -69.9 M | -63.5 M | -48.7 M | -37.2 M | -35.8 M | -33.5 M | -21.4 M | -18 M | -11.6 M | -12.1 M | -9.05 M | -6.25 M | -7.23 M | -7.57 M | -6.23 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zinsaufwendungen |
70 K | 24 K | -499 K | - | -603 K | -63 K | -277 K | - | 99 K | 149 K | -289 K | - | -117 K | -61 K | 1.54 M | - | -16 K | 5 K | 14 K | - | -61 K | 228 K | -253 K | - | -22.2 K | -32.9 K | -31.5 K | - | -801 | 397 | - | - | 23.6 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -61.6 M | - | - | - | -175 M | - | -152 M | -148 M | -129 M | - | -127 M | -194 M | -124 M | 130 M | -129 M | -115 M | -98.7 M | -106 M | -69.8 M | -63.4 M | -48.6 M | -37.2 M | -35.8 M | -33.5 M | -21.4 M | -18 M | -11.6 M | -12.1 M | -9.05 M | -6.25 M | -7.23 M | -7.57 M | -6.23 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsaufwand |
244 M | 229 M | 234 M | - | 247 M | 215 M | 220 M | - | 175 M | 165 M | 143 M | - | 134 M | 195 M | 125 M | - | 130 M | 116 M | - | - | 69.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
122 M | 128 M | 130 M | - | 146 M | 111 M | 102 M | - | 78.4 M | 63.2 M | 51.2 M | - | 45.8 M | 49 M | 40.6 M | - | 37 M | 28.4 M | 29.5 M | - | 18.6 M | 12.8 M | 8.17 M | - | 6.27 M | 5.95 M | 4.04 M | - | 2.07 M | 1.71 M | 1.82 M | - | 1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung